GENERAL
Sun Pharmaceuticals To Acquire Organon In $11.75-Bn All-Cash Deal
Sun Pharmaceutical Industries Ltd, leading specialty generics company, will acquire Organon at $14 per share in an all-cash transaction, valuing the company at an enterprise value of $11.75 billion, funded through internal accruals and borrowings. The transaction will be executed through a merger of Organon with a subsidiary of Sun Pharma, with Organon surviving the […]
CW Bureau
·
Apr 27, 2026
GENERAL
US Department Of Justice Drop All Charges Against Vasudha Pharma
Vasudha Pharma Chem Ltd said the U.S. Department of Justice has dropped all charges against it after finding no evidence of wrongdoing, with no outstanding criminal or civil liabilities remaining against the company. The company said it has entered into a Non-Prosecution Agreement with the DOJ on April 16, 2025 and had strengthened its compliance […]
CW Bureau
·
Apr 17, 2026
HOSPITALITY
Rubicon Research To Buy 85% Stake In Arinna Lifesciences For ₹175.92 Cr
Rubicon Research Ltd has entered into definitive agreements to acquire an 85% stake in Arinna Lifesciences Ltd for a consideration of ₹175.92 crore, marking a strategic expansion in the domestic formulations market. The transaction, which values Arinna at an enterprise value of ₹200 crore on a cash and debt-free basis, is expected to be concluded […]
CW Bureau
·
Apr 15, 2026
